Eli Lilly & Co. (LLY)
1178.99
+9.39
(+0.80%)
USD |
NYSE |
Oct 09, 13:47
Eli Lilly Profit Margin (Quarterly) : 30.88% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.88% |
| March 31, 2026 | 37.36% |
| December 31, 2025 | 34.40% |
| September 30, 2025 | 31.72% |
| June 30, 2025 | 36.39% |
| March 31, 2025 | 21.68% |
| December 31, 2024 | 32.59% |
| September 30, 2024 | 8.48% |
| June 30, 2024 | 26.25% |
| March 31, 2024 | 25.58% |
| December 31, 2023 | 23.41% |
| September 30, 2023 | -0.60% |
| June 30, 2023 | 21.21% |
| March 31, 2023 | 19.32% |
| December 31, 2022 | 26.54% |
| September 30, 2022 | 20.91% |
| June 30, 2022 | 14.68% |
| March 31, 2022 | 24.36% |
| December 31, 2021 | 21.58% |
| September 30, 2021 | 16.39% |
| June 30, 2021 | 20.63% |
| March 31, 2021 | 19.91% |
| December 31, 2020 | 28.45% |
| September 30, 2020 | 21.05% |
| June 30, 2020 | 25.68% |
| Date | Value |
|---|---|
| March 31, 2020 | 24.86% |
| December 31, 2019 | 24.46% |
| September 30, 2019 | 22.90% |
| June 30, 2019 | 23.55% |
| March 31, 2019 | 11.02% |
| December 31, 2018 | 19.89% |
| September 30, 2018 | 20.61% |
| June 30, 2018 | -4.15% |
| March 31, 2018 | 23.51% |
| December 31, 2017 | -26.89% |
| September 30, 2017 | 9.82% |
| June 30, 2017 | 17.31% |
| March 31, 2017 | -2.12% |
| December 31, 2016 | 13.40% |
| September 30, 2016 | 14.99% |
| June 30, 2016 | 13.83% |
| March 31, 2016 | 9.05% |
| December 31, 2015 | 8.90% |
| September 30, 2015 | 16.12% |
| June 30, 2015 | 12.07% |
| March 31, 2015 | 11.40% |
| December 31, 2014 | 8.37% |
| September 30, 2014 | 10.27% |
| June 30, 2014 | 14.86% |
| March 31, 2014 | 15.54% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.86% |
| Merck & Co., Inc. | -8.06% |
| Pfizer Inc. | -1.64% |
| Bristol Myers Squibb Co. | 25.54% |
| Structure Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 99.80% |
| Return on Assets | 22.74% |
| Return on Invested Capital | 37.27% |
| Gross Profit Margin (Quarterly) | 85.78% |
| Operating Margin (Quarterly) | 54.22% |
| Return on Net Operating Assets | 30.49% |